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Pathogenic Yersinia have a pronounced tropism for lymphatic tissues and harbor a virulence plasmid that encodes a
type III secretion system, pTTSS, that transports Yops into host cells. Yops are critical virulence factors that prevent
phagocytosis by macrophages and neutrophils and Yersinia mutants lacking one or more Yops are defective for
survival in lymphatic tissues, liver, and gastrointestinal tract. However, here we demonstrate that Y. pseudotuberculosis
(Yptb) mutants lacking the pTTSS survived as well as or better than wild-type (WT) Yptb in the mesenteric lymph nodes
(MLN). Infection with pTTSS mutants caused lymphadenitis with little necrosis, whereas infection with WT Yptb
provoked lymphadenitis with multiple necrotic suppurative foci. Gentamicin protection assays and microscopic
examination of the MLN revealed that pTTSS mutants resided extracellularly adjacent to B and T lymphocytes in the
cortex and paracortex. WT Yptb was found extracellularly adjacent to neutrophils and macrophages in necrotic areas
and adjacent to B and T lymphocytes in less-inflamed areas. To determine whether lymphocytes protected pTTSS
mutants from phagocytic cells, Rag1
 / mice were infected with pTTSS mutants or WT Yptb. pTTSS mutants but not WT,
were impaired for survival in MLN of Rag1
 /  mice, suggesting that lymphocyte-rich regions constitute a protective
niche for pTTSS mutants. Finally, we show that invasin and the chromosomally encoded TTSS were not required for
Yptb survival in MLN. In summary, chromosomally encoded factors are sufficient for Yptb replication in the cortex and
paracortex of MLN; the pTTSS enables Yersinia to survive within phagocyte-rich areas of lymph nodes, and spread to
other tissues.
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e86. DOI: 10.1371/journal.ppat.0020086
Introduction
One hallmark of Yersinia infections is colonization of the
lymph nodes. After subcutaneous delivery of Y. pestis by the
bite of an infected ﬂea, Y. pestis usually migrates to draining
lymph nodes and causes a fulminant infection leading to
severe swelling of these organs, termed buboes, and then
spreads systemically [1]. Y. pestis is thought to have evolved
from the enteric pathogen, Y. pseudotuberculosis (Yptb), about
1,500–20,000 y ago [2]. However, Y. pestis acquired two
additional plasmids important for its life cycle [3]. Despite
the high degree of genetic similarity between the two species
[2], infections with Yptb in humans occur after ingestion of
contaminated food or water and are generally mild and self-
limiting [1]. However, a frequent clinical manifestation of
Yptb infections is mesenteric lymphadenitis [1,4]. Infection in
humans with the more distantly related Y. enterocolitica (Ye)
[2,5] generally produces gastrointestinal pathology as well as
mesenteric lymphadenitis [1,4]. Thus, although enteric
Yersinia species and Y. pestis use different means of trans-
mission and cause different syndromes, all three species have
a pronounced tropism for lymphoid tissues [1,4].
All three pathogenic Yersinia species carry a highly
homologous 70-Kb virulence plasmid, termed pIB1 in Yptb,
pYV in Ye, and pCD1 in Y. pestis [6–8]. These plasmids are
key virulence factors that encode the structural (Ysc),
regulatory (Lcr), and effector (Yops) proteins, of a type III
secretion system (TTSS) [9,10]. The structural genes of the
pIB1-encoded TTSS (pTTSS) are primarily encoded in two
operons, yscAL and yscNU. These two operons are separated
by a bicistronic operon containing virG, which encodes a
lipoprotein [11], and the lcrF, which encodes the transcrip-
tional activator of the ysc and yop promoters [12,13]. The
pTTSS allows Yersinia to secrete and translocate Yops into
host cells [9]. It is thought that Yops are critical in allowing
Yersinia spp. to reside extracellularly in infected tissues and
to resist clearance by normal innate immune functions by a
number of mechanisms, including apoptosis, down-regu-
lation of pro-inﬂammatory responses to Yersinia, and
prevention of phagocytosis [9,14–23]. For instance, YopJ
triggers apoptosis in macrophages in culture and Mac1
þ
cells in the mesenteric lymph nodes (MLN) of mice [15–
1 7 , 2 4 ] .I nc u l t u r e dc e l l s ,Y o p H ,Y o p O ,Y o p E ,a n dY o p T
have all been implicated in preventing phagocytosis by
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YopH, and YopJ decrease the levels of pro-inﬂammatory
cytokines and chemokines [17,22,23,25]. Thus, Yops disrupt
normal processes of cultured cells and inhibit innate host
defense mechanisms in infected tissues.
The importance of Yops for the virulence of pathogenic
Yersinia spp. has been studied in many different animal
models and by different routes of infection [24,26–31]. In
Yptb, yop mutants are attenuated for virulence after intra-
gastric, intraperitoneal, or intravenous inoculation
[24,28,29,32], and several yop mutants are defective for
colonizing intestinal and lymphoid tissues of mice [24,27].
In addition to the pTTSS, Y. pestis, Yptb, and highly
pathogenic Ye subspecies each have a chromosomally
encoded TTSS, cTTSS [33,34]. The cTTSS in Ye is important
for virulence [35–37], but differs considerably from the
cTTSS encoded by Y. pestis and Yptb, and the role of the Y.
pestis and Yptb cTTSS has not been extensively studied
[33,38].
Our previous work demonstrated that Yptb strains
lacking one or more Yops were deﬁcient in colonization
of the gastrointestinal (GI) tract, Peyer’s patches (PP), and
MLN [27]. In control studies, we tested the ability of
strains lacking the entire pTTSS to colonize different
tissues after intragastric inoculation of mice, expecting
that these strains would be severely attenuated. Surpris-
ingly, pTTSS mutants colonized the MLN as efﬁciently as
or better than wild-type (WT), although they were
defective in colonizing the GI tract, spleen, and liver.
Further investigation into the behavior of WT and pTTSS
mutants revealed that both were found predominantly in
the cortex and paracortex of the MLN, and both remained
extracellular regardless of the presence of the pTTSS. Our
results indicate that chromosomally encoded factors are
necessary and sufﬁcient for Yptb to replicate within B and
T lymphocyte zones of MLN.
Results
pTTSS Mutants Colonize the MLN and PP, but Not the GI
Tract or Spleen
To determine whether the pTTSS was required for coloniza-
tionofvarioustissuesafterintragastricinoculation,severalYptb
mutantswithdeletionsintheoperonsencodingthepTTSSwere
created. Deletions of the yscBL operon, the yscNU operon, or
both operons and the virGlcrF operon, designated yscBU, were
generated. A strain lacking the pIB1 virulence plasmid was also
testedtodeterminewhetherotherplasmid-encodedgeneswere
important for colonization. All four pTTSS mutants, yscBL,
yscNU, yscBU, and pIB1
  were used to intragastrically inoculate
BALB/cmice,andtheircolonizationlevelswerecomparedtothe
isogenic WT strain, YPIIIpIB1. At 6 h, 2 d, or 5 d post-
inoculation, the lumen contents of the ileum, cecum, and
ascending colon, the PP, cecal lymph node (CLN), MLN, and
spleen were dissected, and the colony forming units per gram
(cfu/g) tissue determined.At6 h post-inoculation,nodifference
in colonization of any tissue was observed between the yscBU
mutant and WT YPIIIpIB1 (Figure 1 A–1E, and unpublished
data).At 2 dpost-inoculation,the pTTSSmutantswereseverely
attenuated for colonization throughout the GI tract, PP, CLN
(Figure 1F–1J, and unpublished data). In contrast, the level of
colonization of the MLN was similar between WT, and three of
the four TTSS mutants, yscBL, yscNU, and pIB1
  indicating that
theTTSSwasnotrequiredforcolonizationofMLN.At5dpost-
inoculation, the defect in colonization of the pTTSS mutants
was evident throughout the GI tract and spleen, whereas
colonization levels of all pTTSS mutants in the MLN, PP, and
CLNweresimilartoWTorinsomecaseshigherthanWT(Figure
1K–1O and unpublished data).
To determine whether pTTSS mutants colonized other
strains of mice efﬁciently, C57Bl6/J mice were infected with
WT YPIIIpIB1, yscBU, or pIB1
 (Figure 1K–1O). As observed in
BALB/c mice, the pTTSS mutants colonized the PP and MLN
at levels comparable to WT YPIII and were deﬁcient in
colonizing the ileum, cecum, and spleen. Therefore, the
pTTSS or other elements encoded on the pIB1 plasmid are
not required for Yptb survival and replication in the PP or
MLN at 5 d post-inoculation in BALB/c or C57Bl6/J mice.
To conﬁrm that the ability of Yptb to colonize the MLN in
the absence of pTTSS was not due to a unique property of the
YPIII strain, similar studies were performed using the Yptb
strain, IP2666. IP2666, unlike YPIII, has a functional copy of
PhoP which enables IP2666 Yptb to replicate intracellularly in
bone marrow-derived macrophages [38]. Because IP2666 is
slightly more virulent than YPIII during intragastric infec-
tions of mice (L. Logsdon and J. Mecsas, unpublished data),
mice were sacriﬁced at day 4 post-inoculation (Figure 1K–1O).
Surprisingly, the IP2666 pTTSS mutants, yscNU, and pIB1
 ,
colonized the MLN at levels 10-fold higher than WT IP2666
(Figure 1K–1O). As observed for YPIII, the IP2666 pTTSS
mutants were recovered in signiﬁcantly fewer numbers in the
ileum and spleen; however, about 10-fold more IP2666 pTTSS
than YPIII pTTSS were recovered in the spleen, consistent
with the increased virulence of the IP2666 strain (Figure 1O).
Since other Gram-negative bacteria reside in the lymphoid
tissues for long periods of time [39], and commensal bacteria
remainaliveindendriticcellsintheMLNforseveraldays[40],a
mouse-commensal Escherichia coli strain isolated from mouse
feces (see Materials and Methods) was used to intragastrically
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Synopsis
The pathogenic bacteria, Yersinia, synthesize an apparatus called a
type III secretion system, which transports bacterial proteins, Yops,
from the bacteria into important immune cells, such as macro-
phages and neutrophils. Normally, macrophages and neutrophils
control bacterial infections by ingesting the bacteria; however, the
Yops inactivate these immune cells, which in turn, enable Yersinia to
replicate extracellularly and cause disease in many types of tissues.
Pathogenic Yersinia are frequently found in lymph nodes of infected
hosts, and the Yops are important for the bacteria to replicate and
cause disease in lymph nodes since Yersinia mutants that lack Yops
do not colonize lymph nodes efficiently. Surprisingly, the authors
found that Yersinia pseudotuberculosis lacking the type III secretion
system colonizes the mesenteric lymph nodes and survives
extracellularly next to lymphocytes. However, in mice lacking
lymphocytes, the type III secretion mutants did not survive although
wild-type Yersinia did. The authors’ findings reveal that other
bacterial factors are sufficient for mesenteric lymph node (MLN)
colonization of Yersinia and that lymphocytes provide a protective
niche for Yersinia strains lacking the type III secretion system.
Potentially, these avirulent mutant strains, which persist for at least 5
d in the mesenteric lymph nodes, could be used as live attenuated
vaccines to protect against Yersinia infections, or as carriers of other
antigens.PLoS Pathogens | www.plospathogens.org September 2006 | Volume 2 | Issue 9 | e86 0818
Yersinia Replication in Lymph Nodesinfect BALB/c mice. At 6 h post-inoculation, E. coli colonized
the GI tract and lymphatic tissues at levels comparable to or
higher than Yptb (Figure 1A–1E). However, by 2 d post-
inoculation, E. coli were undetectable in the MLN and were
almost cleared from the PP and the CLN (Figure 1F–1J and
unpublisheddata).TheseresultsindicatethattheabilityofYptb
to survive in the MLN for up to 5 d is not a general property of
all Gram-negative enteric bacteria. In conclusion, Yptb colo-
nization of the MLN occurs in the absence of the pTTSS or
otherpIB1-encodedgenes,demonstrating thatchromosomally
encoded factors are sufﬁcient for MLN colonization.
pTTSS Mutants Cause a Milder Inflammatory Response in
the MLN Than WT Yersinia
To investigate the host response to infection by WT and
pTTSS mutants in the MLN, infected MLN were analyzed by
histology. The IP2666 strain was selected for this experiment,
since the IP2666 strain was more virulent than the YPIII
strain. BALB/c mice were inoculated intragastrically with 2 3
10
9 WT IP2666 or the pIB1
  mutant, and the MLN were
harvested 4 d post-inoculation and prepared for histology.
Gross anatomical analysis of the MLN showed that both
strains caused enlargement of the MLN, i.e., hyperplasia,
compared to uninfected MLN (Table 1 and Figure 2).
Histological analysis of uninfected MLN showed normal
follicular lymphocytic areas (Figure 2A) adjacent to a
compact paracortex (Figure 2C and 2D) with no evidence of
necrotic lesions or lymphoid hyperplasia (Figure 2A–2D). In
most mice infected with WT IP2666, one or more MLN had
multiple necrotic foci located at the edge of the MLN and
close to the germinal centers (Table 1 and Figure 2E) or in the
paracortex (Table 1). Areas of necrosis contained bacteria
Figure 2. MLN Histopathology during WT or pIB1
  Infection
BALB/c mice were intragastrically inoculated with 2310
9 WT or IP2666 pIB1
 , and MLN were processed for H&E staining 4 d later. MLN sections from
uninfected (Uninf.) (A–D), WT infected (E–H), and pIB1
  infected (I–L) are shown at 153,4 0 3,9 0 3, and 4503 magnification. White boxes indicate
magnified areas in the next slide. White arrow points to the bacterial foci, black arrow to neutrophils. Scale bars correspond to 133 lm for 153
magnification, 50 lm for 403 magnification, 22 lm for 903 magnification, and 4.4 lm for 4503 magnification. Pictures shown are representative of
multiple fields and samples from 16 MLN infected with WT or 14 MLN infected with pIB1
 .
C, cortex; gc, germinal center; M, medulla; P, paracortex.
DOI: 10.1371/journal.ppat.0020086.g002
Figure 1. pTTSS Is Not Required for MLN Colonization
BALB/c or C57BL6/J mice were intragastrically inoculated with 2310
8 WT YPIII, YPIII yscBL, YPIII yscNU, YPIII yscBU, or YPIII pIB1
 , and colonization levels
of the ileum (A), (F), and (K), cecum (B), (G), and (L), PP (C), (H), and (M), MLN (D), (I), and (N), and spleen (E), (J), and (O) were determined at 6 h (A–E), 2d
(F–J), and 5 d (K–O) post-inoculation. BALB/c mice were intragastrically inoculated with 2 3 10
8 mouse commensal E. coli, and colonization levels of
tissues were studied at 6 h (A–E) and 2 d post-inoculation (F–J). BALB/c mice were intragastrically inoculated with 2310
9 of WT IP2666, IP2666 yscNU, or
IP2666 pIB1
 , and colonization levels were determined at 4 d post-inoculation ( [K–O], middle section).
Data are from 4–12 mice from at least two different experiments. All data was combined for each strain, tissue, and time point. Each square represents
the log cfu/g tissue from one mouse; open squares indicate that less than 10 cfu were recovered per tissue, and bars represent the geometric mean.
Asterisks (*) and black circles ( ) indicate statistically significant differences between the WT and the mutants, calculated by the t test (*p , 0.01) or by
Mann-Whitney ( U , 0.05), respectively.
DOI: 10.1371/journal.ppat.0020086.g001
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Yersinia Replication in Lymph Nodes(Figure 2G, arrow), neutrophils, eosinophilic amorphous
material, and many apoptotic nuclei (Figure 2H). These
ﬁndings contrasted notably with MLN from mice infected
with the pIB1
  mutant, which had lymphoid hyperplasia and
occasionally a necrotic cell but no evidence of acute necrosis
(Table 1 and Figure 2I–2L). Although WT-infected MLN
presented with neutrophil inﬁltration primarily around the
necrotic foci, the pIB1
 -infected MLN generally presented
with diffused inﬁltration of neutrophils in the paracortex.
Despite the fact that IP2666 pTTSS mutants were recovered
at 10 times the level of WT IP2666 (Figure 1N), no extensive
necrosis was observed, suggesting that one or more compo-
nents of the pTTSS trigger an acute inﬂammatory response
leading to necrosis, whereas pTTSS mutants persist, causing
milder inﬂammatory response.
The pIB1
  Strain Localizes in Lymphocyte-Rich Areas
Immunohistochemistry studies were undertaken to deter-
mine the microenvironment of WT and pTTSS mutants in
the MLN. WT IP2666 microcolonies were found in necrotic
areas (Figure 3), in lymphocyte-rich areas of the cortex and
paracortex that had no evidence of acute necrosis although
apoptotic nuclei were often observed close to the bacteria
(Figure 3G–3I), and in the medulla (unpublished data). pIB1
 
microcolonies were found in lymphocyte areas of the cortex
and paracortex, but not in the medulla (Figure 3J–3L and
unpublished data). In the cases in which inﬁltration of
phagocytes were observed, pIB1
  mutants were not detected
in these areas (unpublished data), unlike in necrotic areas
containing WT bacteria.
The cortex and paracortex are primarily composed of
lymphocytes [41,42]. In order to conﬁrm the cell types
adjacent to Yptb, immunoﬂuorescence studies were per-
formed. Serial MLN sections from infected BALB/c mice
were stained with anti-Yptb and either a mixture of antibodies
that recognize lymphocytes (CD4, CD8, and B220) (Figure 4A–
4F) or an antibody that recognized macrophages and
neutrophils (CD11b) (Figure 4G–4L). Yptb pTTSS mutants
were found in lymphocyte-rich areas whereas WT Yptb was
occasionally observed adjacent to CD11b
þ cells (Figure 4G–
4L). To determine whether Yptb had a preference for either B
or T cells, sections were stained with anti-CD4 and anti-CD8
or anti-B220 and antibody against Yptb. Both WT and pTTSS
mutant strains were found in close proximity to both T and B
lymphocytes (unpublished data), indicating no overt prefer-
ence for either type of lymphocyte.
pTTSS Mutants Are Deficient in Colonization of Lymphoid
Tissues in Rag1
 /  Mice
Since pTTSS mutants survive in B and T lymphocyte areas
of the MLN, we hypothesized that B and T cell–rich areas
might confer a protective niche from neutrophils and
macrophages. To determine whether the absence of B and
T cells rendered the IP2666 pIB1
  less capable of surviving in
the MLN, BALB/c or congenic Rag1
 /  mice were infected
with WT IP2666 or IP2666 pIB1
 . Rag1
 /  mice lack mature B
and T lymphocytes, although small numbers of immature
lymphocytes are present [43]. Four days post-inoculation, the
MLN and ileum colonization levels were compared in the
BALB/c and Rag1
 /  mice (Figure 5). Notably, the size and
weight of the MLN in Rag1
 /  mice varied depending on
whether mice had been infected with WT IP2666 or pIB1
 
strains (Figure 5A). Rag1
 /  mice infected with pTTSS
mutants had larger MLN than Rag1
 /  MLN infected with
WT Yptb (Figure 5A), consistent with the idea that WT IP2666
can inhibit the pro-inﬂammatory response [22,23,25]. There-
fore recovery of bacteria in the MLN was calculated both as
cfu/g and cfu/MLN (Figure 5B). Total colonization levels in
the MLN were similar in WT IP2666–infected BALB/c and
Rag1
 / mice (Figure 5B). In contrast, colonization of the MLN
by IP2666 pIB1
  in Rag1
 /  mice was 16-fold lower than
colonization levels in BALB/c mice (Figure 5B). Levels of the
IP2666 pIB1
 in the ileum of BALB/c and Rag1
 / mice showed
no differences (Figure 5C), indicating that the lack of
recovery in the MLN of the pTTSS mutant in Rag1
 /  mice
was not secondary to a reduced ability to colonize the GI tract
in Rag1
 /  mice.
Since Rag1
 /  mice lack PP, it was conceivable that the
pIB1
  mutants colonize the MLN poorly because they are
unable to reach the MLN due to the lack of PP, rather than to
survive in the MLN. Thus, Rag1
 /  mice were infected
intraperitoneally (i.p.) to bypass any requirement for trafﬁck-
ing from the GI tract through the PP to the MLN.
Unexpectedly, after intraperitoneal inoculation with either
WT or pTTSS mutants, the MLN were not detectable by eye
Table 1. MLN Histopathological Analysis
Strain Mouse MLN
a Hyperplasia
b Neutrophils
c Necrosis
d,e
WT IP2666 1A 2 2 C , P
f 1C
B 2 2C 3C
C2 0 0
D3 0 0
E3 0 0
2A 2 0 0
B1 0 0
C2 0 0
D2 0 0
3A 2 0 0
B 2 2C 3C
C2 0 0
D 3 2C 3C
4A 0 0 0
B 3 3C ,P 3C ,P
C2 0 0
IP2666 pIB1
  1A 2 2 P 1 P
B0 1 P 0
C0 0 0
2A 1 0 0
B2 0 0
C2 0 0
D2 2 P 0
3A 2 0 0
B 3 3C ,P 1P
C3 2 P 0
4A 3 0 0
B3 1 P 0
C 3 1P 0P
D2 1 C , P 1
aThree to five MLN per mouse were analyzed.
bDefined by tissue enlargement: 0 (not detected), 1 (mild), 2 (moderate), and 3 (severe).
cDefined by neutrophil infiltration: 0 (not detected), 1 (mild), 2 (moderate), and 3 (severe).
dAreas of neutrophil infiltration or necrosis: C, cortex; P, paracortex.
eDefined by cellular debris: 0 (not present), 1 (mild), 2 (moderate), and 3 (severe).
fStatistically significant difference between WT and pIB1
  in the MLN displaying signs of
necrosis, calculated by Mann-Whitney, U , 0.05.
DOI: 10.1371/journal.ppat.0020086.t001
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 /  mice. Our inability to detect MLN could have been
a result of their initial small size and lack of inﬂammatory
response after i.p. inoculation, or alternatively, the MLN in
the Rag1
 /  mice may have been destroyed by a robust
immune response to infection prior to dissection.
pTTSS Mutants Localize Extracellularly in the MLN
Since it is well documented that the pTTSS allows Yersinia
spp. to remain extracellular while docked to phagocytic cells
[9], we investigated whether the pTTSS mutants were
extracellular or intracellular in the MLN using an ‘‘ex vivo’’
gentamicin protection assay (see Materials and Methods).
BALB/c mice were infected intragastrically with WT YPIII, WT
IP2666, or pTTSS mutants, and 4- or 5-d post-inoculation cell
suspensions of MLN were treated with gentamicin (Figure 6A).
Although the differences were not signiﬁcant, more pTTSS
mutants were protected from gentamicin than the isogenic
WT strains. However, only 1% of the YPIII yscBL and 3.4% of
the IP2666 pIB1
  mutant were protected, indicating that over
96% of the pTTSS mutants were extracellular. The observa-
tion that more WT IP2666 were protected from gentamicin
than WT YPIII may reﬂect the ability of the IP2666 strain to
survive and replicate within macrophages [38]. As a positive
control, nearly 15 % of Salmonella typhimurium were intra-
cellular in the MLN at 4 d post-inoculation. Overall, these
results indicate that the majority of Yptb remain extracellular
in the MLN, even in the absence of a functional pTTSS.
The pTTSS is important for Yptb to inhibit phagocytosis by
macrophages, neutrophils, and epithelial cells in cell culture
assays [9]; thus, it was surprising that the vast majority of the
pTTSS mutants remained localized extracellularly. To con-
ﬁrm that the pTTSS mutants were phagocytosed more
efﬁciently than WT, gentamicin protection assays were
performed using the murine macrophage-like cell line,
RAW264.7. As expected, higher level of uptake by the
macrophages of the pTTSS mutants was observed compared
to WT YPIII or WT IP2666 (Figure 6B). WT IP2666 was
phagocytosed more efﬁciently than YPIII, an observation
consistent with our ‘‘ex vivo’’ gentamicin protection assays
and previous results by others [38]. Yptb pTTSS mutants
efﬁciently invade some types of non-professional phagocytes,
such as HEp-2 cells, by binding to a4- or a5-b1 integrins using
the bacterial protein, invasin [44,45]. Since the areas of the
MLN infected by pTTSS mutants are composed primarily of
Figure 3. Yptb Localizes in the Cortex and Paracortex of the MLN
BALB/c mice were intragastrically inoculated with 2 3 10
9 WT or IP2666 pIB1
 . At 4 d post-inoculation, MLN were harvested and stained for Yptb
followed by hematoxylin staining. Picture sections of uninfected (A–C), WT infected (D–I), and pIB1
  infected (J–L) MLN were taken at 1503, 9003, and
4,5003magnification. White boxes indicate magnified areas in the next slide. Arrows point to Yptb microcolonies. Scale bars correspond to 133 lm for
153magnification, 22 lm for 903magnification, and 4.4 lm for 4503magnification. Pictures shown are representative of multiple fields and samples
from MLN infected with WT or pIB1
 .
C, cortex; gc, germinal center; M, medulla; P, paracortex.
DOI: 10.1371/journal.ppat.0020086.g003
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integrins [46,47], gentamicin protection assays were per-
formed on two human T cell lines, SUP-T1 and H9, and
primary B and T lymphocytes isolated from MLN after
incubation with WT and pTTSS mutants. The pTTSS mutants
were not efﬁciently internalized by either T cell lines or by
primary B and T lymphocytes isolated from MLN (Figure 6B
and unpublished data). These results are consistent with the
‘‘ex vivo’’ gentamicin protection assays, indicating that
pTTSS mutants are extracellular in lymphocyte rich areas.
Invasin and the cTTSS Are Not Necessary for Survival in
the MLN
Since chromosomal factors must play a role in Yptb survival
in the MLN, two chromosomally encoded factors, invasin and
cTTSS, were tested for growth in the MLN when the pTTSS
was not present. Invasin-deﬁcient strains (inv
 ) are less
competentthanWTincolonizingthePPfollowingintragastric
inoculation[30,48], indicatingthatinvasiniscrucialforYptbto
reach and/or survive in the PP. To evaluate the role of invasin
in a pIB1
 background, BALB/c mice were infected intragastri-
cally and colonization levels were assessed 5 d post-inocu-
lation. Notably, a pIB1
 inv
 strain was 100-fold more deﬁcient
in the colonization of the ileum compared to pIB1
 , indicating
thatinvasinplays aroleinbacterialsurvivalintheileumthatis
independent of pTTSS (Figure 7A). In the PP and MLN, the
pIB1
 inv
 strain was more deﬁcient than pIB1
 in colonization
(Figure 7A); however, the lower levels in lymph tissues could
reﬂect the lower levels of bacteria in the ileum. In order to
bypass the requirement for invasin in the ileum, mice were
infected intraperitoneally. No difference was observed be-
tween the pIB1
 and the pIB1
 inv
 strains in MLN colonization
after i.p. inoculation, indicating that although invasin is
required for reaching the MLN after oral inoculation, it is
not required for Yptb pIB1
  survival in MLN (Figure 7B).
To determine whether the cTTSS is important for MLN
colonization, BALB/c mice were intragastrically infected with
pIB1
  and pIB1
 cTTSS mutants. No differences were observed
in the colonization of the lumen, PP, MLN, or spleen between
pIB1
  and pIB1
 cTTSS at 5 d post-inoculation (Figure 7C).
Thus, the cTTSS is not required for MLN colonization in the
absence of pIB1.
Figure 4. pTTSS Mutants Are Adjacent to B and T Lymphocytes Whereas WT Is Adjacent to B and T Lymphocytes and CD11b
þ Cells
BALB/c mice were intragastrically inoculated with 2 3 10
9 WT IP2666 or IP2666 pIB1
 . At 4 d post-inoculation, MLN were harvested, sectioned, and
examined by fluorescence microscopy. Staining with antibodies to Yptb (red) (A), (D), (G), and (J), to CD4-CD8-B220 (green) (B) and (E), or to CD11b
(green) (H) and (K) was performed, and images merged (C), (F), (I), and (L). Pictures show the cortex–paracortex and are representative of multiple fields
and samples for WT-infected mice and pIB1 mice stained with CD4-CD8-B220. Fewer fields had pIB1 bacteria and CD11bþcells. Scale bars correspond to
22 lm for 9003 magnification.
DOI: 10.1371/journal.ppat.0020086.g004
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A prominent clinical feature of infection by pathogenic
Yersinia is lymphadenitis, as large buboes [1] and mesenteric
lymphadenitis [4] are frequent symptoms associated with
infection by Y. pestis and enteric Yersinia pathogens, respec-
tively. Little is known about the factors involved in Yersinia
survival in the lymph nodes, although deletion of several Yops
reduces the ability of Yersinia to colonize PP and MLN, which
suggests that these Yops are required for reaching and/or
replicating in lymph nodes [27,31]. Here, we show that Yptb
replicates extracellularly in the cortex and paracortex of the
MLN in the absence of pTTSS and Yops, indicating that the
ability to reach and replicate in lymphocyte-rich areas is
driven by chromosomally encoded factors. WT Yptb infection
Figure 5. B and T Lymphocytes Are Important for pIB1
  Colonization in
the MLN
BALB/c or Rag1
 /  mice were intragastrically inoculated with 2310
9 WT
IP2666 or IP2666 pIB1
 .
(A) Size and weight of MLN from BALB/c or Rag1
 / mice that were either
uninfected or infected with WT IP2666 or IP2666 pIB1
  were measured.
(B) and (C) Colonization of the MLN or luminal content of the ileum 4 d
post-intragastric inoculation of BALB/c or isogenic Rag1
 /  mice was
determined. Each square indicates the cfu from one mouse calculated as
log cfu/MLN (B) or the log cfu/g of luminal content of the ileum (C); bars
represent the geometric mean. Each experiment was performed with
two to three mice and repeated three times. Asterisks (*) and black
circles ( ) indicate statistically significant differences between the
number of pIB1
  recovered from BALB/c mice versus Rag1
 / , calculated
by the t test (*p , 0.05) or by Mann-Whitney ( U , 0.05), respectively.
DOI: 10.1371/journal.ppat.0020086.g005
Figure 6. Yptb pTTSS Mutants Remain Extracellular in the MLN and Are
Not Efficiently Internalized by B or T Lymphocytes in Culture
(A) Single-cell suspensions of Yptb-infected MLN were assayed for the
presence of intracellular bacteria using a gentamicin protection assay.
BALB/c mice were intragastrically inoculated with WT YPIII (n ¼ 6 mice),
YPIII yscBL (n¼5 mice), WT IP2666 (n¼5 mice), IP2666 pIB1
 (n¼7 mice),
or S. typhimurium (n ¼ 4 mice). Four days post-inoculation with IP2666
strains or 5 d post-inoculation with YPIII strains, the percentage of
intracellular bacteria was assessed by generating a single-cell suspension
of the MLN and treating half the suspension with gentamicin and half
without gentamicin (see Materials and Methods).
(B) Murine macrophage RAW264.7 cells, human T cells SUP-T1, and B and
T lymphocytes isolated from MLN (see Materials and Methods) were
infected with WT YPIII, YPIII yscBL, WT IP2666, or IP2666 pIB1
  strains at
MOI of 10:1 for 30 min, and then treated with gentamicin for 90 min. The
data are presented as 100 times the number of gentamicin-resistant
bacteria divided by the number of input bacteria. Data from one
representative experiment done in triplicate is shown. All experiments
were performed at least three times.
DOI: 10.1371/journal.ppat.0020086.g006
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mutants induced mild lymphadenitis, demonstrating that
the presence of pTTSS triggers a more acute host inﬂamma-
tory response. Furthermore, B and T lymphocytes appear to
provide a protective niche for pTTSS mutants since their
absence results in signiﬁcantly lower colonization levels of the
pTTSS mutants.
Strikingly, a partial complement of Yops is more detri-
mental to the survival of Yptb in the MLN than the complete
absence of pTTSS [24,27]. Strains lacking two or more Yops
colonize the MLN very inefﬁciently [27], and strains lacking
only yopH, yopJ, or yopE have a 5- to 10-fold defect in MLN
colonization [24,27]. One explanation for these observations
is based on the ﬁnding that the translocation apparatus
damaged cultured cells and induced elevated levels of IL-8,
which were decreased by YopH, YopE, or YopJ [25]. By
analogy, during infection with WT or yop mutants, compo-
nents of the pTTSS may damage lymphocytes and trigger
pro-inﬂammatory signals in the MLN, so that in the absence
of one or more Yops, the bacteria are killed by recruited
macrophages and neutrophils. pTTSS mutants may survive
because they do not damage host cells and therefore do not
induce the same pro-inﬂammatory response. In addition,
pTTSS mutants might replicate faster during infection than
strains expressing the pTTSS, as strains lacking pTTSS have a
modest growth advantage compared to WT Yptb in culture
media (unpublished data). Nonetheless, the pTTSS mutants
clearly have a growth advantage over mouse commensal E. coli
in the MLN, indicating that Yptb chromosomal factors enable
the bacteria to persist and replicate in the MLN. With this in
mind, it is conceivable that a common ancestor of Yersinia
may have been a commensal with low pathogenic capability
but with the ability to persist in the MLN or host environ-
ments similar to lymph nodes of mammals. Acquisition of the
pTTSS would have enabled the non-pathogenic species to
spread to other tissue environments of mammals and survive
within the GI tract, enhancing its transmissibility.
Although the Yptb pTTSS mutants are rapidly internalized
by cells that are generally non-phagocytic, such as epithelial
cells [30], pTTSS mutants establish an extracellular niche
surrounded by B and T lymphocytes in lymphoid tissues.
Non-phagocytic cells expressing a4- or a5-b1 integrins
internalize pTTSS mutants in an invasin-dependent manner
at frequencies often 100-fold greater than WT Yptb [30,49].
Although T lymphocytes express a4- and a5-b1 integrins
[46,47], pTTSS mutants were not internalized signiﬁcantly
more than WT Yptb during infection, and did not invade T or
B lymphocytes isolated from MLN. Although lymphocytes are
not generally considered intracellular hosts for bacterial
pathogens, S. enterica is found within late endosomal–
lysosomal compartments in B lymphocytes of the spleen
after intragastric inoculation [50]. Combined, these results
indicate that the cellular mechanisms exploited by Yptb to
prompt its invasion into non-phagocytic cells are not as
active in B and T lymphocytes. In addition, invasin may not
be expressed in the MLN [51].
It is well established that the pTTSS is an essential
virulence organelle that enables Yptb to remain extracellular
in the presence of phagocytes through the anti-phagocytic
action of Yops [9,21,52]. WT Yptb, but not the pTTSS mutants,
was occasionally found associated with macrophages and
neutrophils, suggesting that our inability to detect pTTSS
Figure 7. Invasin and cTTSS Are Not Essential for Yptb Survival in the
MLN
(A) BALB/c mice were intragastrically inoculated with 2310
8 YPIII pIB1 or
YPIII pIB1
 inv
 , and colonization levels of the ileum, PP, MLN, and spleen
were determined 5 d post-inoculation.
(B) BALB/c mice were i.p. inoculated with 2310
6 YPIII pIB1 or YPIII pIB1
 
inv
 , and their colonization levels in the MLN and spleen were
determined 3 d post-inoculation.
(C) BALB/c mice were inoculated intragastrically with 2 310
8 YPIII pIB1
 
or YPIII pIB1
 cTTSS, and colonization levels of the ileum, PP, MLN, and
spleen were determined. Data are from 6–11 mice from at least two
different experiments. Each square represents log 10 cfu/g tissue
recovered from one mouse. Bars represent the geometric mean. Open
squares indicate than less than 10 cfu were recovered per tissue.
Asterisks (*) and black circles ( ) indicate statistically significant differ-
ences between the pIB1
  and either pIB1
 inv
  or pIB1
 cTTSS strains,
calculated by the t test (*p , 0.01) or by Mann-Whitney ( U , 0.05),
respectively.
DOI: 10.1371/journal.ppat.0020086.g007
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þ cells may be due to rapid
internalization and killing of these mutants by phagocytic
cells. Furthermore, in Rag1
 /  mice, WT Yptb had a selective
advantage compared to the pTTSS mutants, suggesting that
pTTSS mutants are compromised for survival in lymph nodes
that lack B and T lymphocytes. In the absence of lymphocytes,
the protective niche may be lost and the bacteria may be
more exposed to phagocytes in the MLN [53]. In the PP, Yptb
ﬁrst encounters dendritic cells, neutrophils, and macro-
phages immediately after transcytosing the M cells [48]. In
contrast to the MLN, the pTTSS mutants colonize the PP
poorly at day 2, suggesting that many pTTSS mutants are
eliminated by these cells prior to reaching the follicular area
rich in B and T cells.
The inability of pTTSS mutants to survive well in Rag1
 / 
mice compared to the isogenic BALB/c mice suggests that
lymphocytes provide a protective niche for pTTSS. However,
it is possible that the lack of PP hindered the pTTSS in
reaching the MLN. If this were true, then the lack of PP was
speciﬁcally detrimental to the pTTSS mutants, since the WT
Yptb was found in the MLN of Rag1
 /  mice. The latter result
indicated that WT Yptb does not require PP for successful
dissemination to the MLN. We attempted to investigate
whether the low levels of pTTSS mutants observed in the
MLN of Rag1
 / mice were replicating in the MLN or were the
result of continual seeding of the MLN from the GI tract. To
eliminate pTTSS mutants in the GI tract and therefore
prevent reseeding, mice were given streptomycin orally as
described in [54]; however, in control experiments we found
that streptomycin delivered orogastrically killed Yptb coloniz-
ing the MLN after i.p. delivery, but not Yptb colonizing the
spleen, which is consistent with results reported about
colonization of the spleen in [54]. Thus, this experimental
approach is unfeasible. Future experiments are directed at
determining where the pTTSS mutants are in the MLN of
Rag1
 /  mice, and the immune response to infection with WT
and pTTSS in lymph nodes.
Common host-driven pathways indiscriminately trafﬁc
bacteria to lymph nodes, in part by dendritic cells binding
to bacteria in the intestinal lumen and then migrating to the
MLN [40]. Consistent with these observations, we found non-
pathogenic E. coli in the MLN at 6 h post-inoculation. Also,
others have reported Yptb and Salmonella in the blood as early
as 30 min after intragastric inoculation [40,55]. It is note-
worthy that at 6 h post-inoculation E. coli colonizes the lumen
at much higher levels than Yptb, but their levels in the MLN
are comparable to Yptb. Thus, Yptb likely use several tactics to
rapidly reach the MLN, including invasin-dependent
[30,48,56] and host-driven mechanisms [40,55], whereas E. coli
either fails to efﬁciently reach the MLN or is rapidly
eliminated by innate immune defenses in the MLN.
The key to the persistence of Yptb pTTSS mutants in the
cortex and paracortex may lie in adherence factors that
facilitate the interaction of Yersinia with lymphocytes or the
underlying extracellular matrix in these areas. We have ruled
out the requirement of invasin, YadA, and potential cTTSS-
secreted factors in MLN colonization. Other candidate
adhesion factors include the pH6 antigen [57] and glyco-
proteins. In other organisms, glycoproteins play a key role in
conferring cellular tropism [58,59], and intriguingly, in some
cases, they have been shown to be sufﬁcient to induce a state
of proliferative unresponsiveness in lymphocytes [58]. One
such example is the MV glycoprotein complex of measles
virus, which interferes with the propagation of the IL-2
receptor signal by blocking activation [58]. One could
envision that the presence of speciﬁc glycoproteins or
speciﬁc sugars on the LPS determines Yptb tropism and/or
moderates inﬂammatory cytokines produced by B and T cells.
In addition, it is tempting to speculate that preferential
interaction with certain subsets of lymphocytes, such as
CD4
þCD25
þ T regulatory cells may further aid Yptb coloni-
zation. In fact, the presence of CD4
þCD25
þT lymphocytes has
been shown to favor the establishment of Helicobacter pylori in
the gastric mucosa by moderating inﬂammation [60].
Despite the key roles that the pTTSS and Yops play in
disease [27], there is a report of a serotype 4a Yptb pIB1
 strain
isolated from a 10-y-old girl diagnosed with acute mesenteric
lymphadenitis [61]. In agreement with our data, character-
ization of that strain in mice as well as another serotype 4a
pIB1
 strain demonstrated that serotype 4a strains lacking the
pIB1 plasmid colonized the MLN at levels comparable to WT
Yptb for up to 7 d [61]. Interestingly, the fate of Ye pTTSS
mutants in the MLN seems to be dependent on Ye serotype. Ye
biotype 1A pYV
 strains have been isolated from symptomatic
patients [62]. On the other hand, a number of experiments
with other Ye biotypes, Ye O3 pYV
 ,Y eO9 pYV
 , and Ye8081
pYV
 , indicate that these strains were eliminated from the
MLN of rabbits, gnonobiotic piglets, or mice within 1 to 3 d
([63–65] and unpublished data). Taken together, these results
indicate that both enteric Yersinia spp. reach the MLN in the
absence of pTTSS, but only a subset of strains ﬂourishes for
longer periods, and suggest that Yptb has speciﬁc chromoso-
mally encoded factors that enhance its survival. A compara-
tive analysis of the chromosomal genomes of Yersinia strains
that persist versus those that fail to persist in the MLN may
reveal factors that enable replication in lymphoid tissues.
Numerous pathogens, including Mycobacterium spp., Salmo-
nella spp., Brucella s p p . ,v i r u s e s ,a n dp a r a s i t e ss u c ha s
Leishmania spp., are capable of producing lymphadenitis
[39,66–69]. These pathogens use a variety of mechanisms to
survive in the MLN. For example, S. typhimurium survives
intracellularly within macrophages in the MLN, where it can
be isolated for up to a year post-inoculation [39]. Brucella suis
survives inside macrophages by inhibiting apoptosis [70], and
Leishmania spp. survive inside granulomas in the MLN [69].
We have shown that Yptb replicates in B and T lymphocytes
areas in a pTTSS-independent manner. The presence of the
pTTSS provokes many necrotic lesions, and allows Yptb to
survive in phagocyte-rich areas cells and invade other organs.
Future directions are aimed at identifying both the bacterial
and host factors that permit replication of Yptb in lymphocyte
rich zones of the MLN to understand the mechanisms driving
the lymphotropism of Yersinia.
Materials and Methods
Bacterial strains. Two virulent serotype III Yptb strains were used:
YPIII pIB1 [27], which has recently been shown to have a mutation in
phoP [38], and IP2666 pIBI [38]. These strains are described as WT
YPIII and WT IP2666. The YPIII pIBI
 kan and IP2666 pIB1
  were
generated by growing WT YPIII kan [27], or WT IP2666 on Luria Agar
supplemented with 20 mM of sodium oxalate, 20 mM MgCl2, and 0.05
% Congo Red Dye. Loss of a functional pTTSS results in white
colonies. The absence of several genes located on different regions of
the plasmid was conﬁrmed by PCR, indicating that the whole plasmid
was lost. The invasin-deﬁcient strain JM494 [30] was cured of pIB1 as
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from the feces of BALB/c mice (Taconic, Hudson, New York, United
States). This strain was transformed with either pBR322 or pBR322-
expressing invasin, generating JMB44 or JMB45, respectively. Ex-
pression of invasin in this E. coli strain increased the uptake by 100-
fold in gentamicin protection assays using HeLa cells (unpublished
data); however, no difference in colonization of the GI tract, PP, or
MLN was observed when either E. coli strains were used to infect mice
(Figure 1 and unpublished data). S. typhimurium, SL1344, was used [39].
Additional mutant strains generated in this study were constructed
in WT YPIII or WT IP2666 by allelic exchange using the suicide
vector pCVD442, and methods described in [27]. Isogenic pTTSS
mutants were constructed by deleting the regions between yscB to
yscL, yscN to yscU, and yscB to yscU. The primer sequences used to
generate the appropriate suicide plasmids were as follows: yscBL
deletion, yscB1-GTGTGAGTCGACGCGGTGGCGCAA GAAAC, yscB2-
GACAGTGCATGCAGTTGGCCAACGCTTG TTGCATTAG; yscL3-
CCAACTGCATGCACTGTCCAGGAGCTATTCGTGAAC; and yscL4-
CTGTCAGAGCTCGTCGCTATAATTGTCTCTAC; yscNU deletion,
yscN1-GTGTGAGTCGACCTACTCCCTGAGATGAAC, yscN2-GA-
CAGTGCATGC AGTTGGCCAAGTGGAATAAGTAATGC, yscU3-
CCAACTGCATGCACTGTCTCA TCAGTGGTGGTAGCT, and
yscU4-CTGTCAGAGCTCCCAATAGCCGGTGTTAATC; and yscBU
deletion, yscB1, yscB2 and yscU1, yscU2. Colonies were screened for
their ability to bind to Congo Red. Deletions were conﬁrmed by PCR
and then Southern blot.
The cTTSS deletion was constructed by deleting the putative
structural genes spiA-ssaV. Primers used to generate the suicide
plasmid were: spiA1-GTGTGAGTC GACCTGTGCCATAAAAGC-
GATCC; spiA2-GACAGTGCATGCAGTTGGTAG CGGAATATCGC;
ssaV3-CCAACTGCATGCACTGTCCACATTTTGCCGTT; and ssaV4-
CTGTCAGAGCTCCCTGTGCAATGCGGATAG. Deletions were con-
ﬁrmed by PCR and then Southern blot. In addition, the pTTSS
mutants were grown at 26 8C and 37 8C, using Yop-inducing, i.e.,
calcium-depleted. medium [71], or non-inducing conditions, i.e.,
23YT supplemented with 5 mM CaCl2.A t2 68C, the growth of the
mutants was comparable to WT. At 37 8C, the pTTSS mutants had a
growth advantage compared to WT in Yop-inducing conditions, but
they grew similarly when grown in non-inducing conditions. Yops
were not secreted when Yptb were grown at 37 8C under Yop-inducing
conditions [27].
The resulting mutants and strains used were given the following
strain numbers: JMB35, YPIII yscBL; JMB31, YPIII yscNU; JMB38, YPIII
yscBU; JMB5, YPIII pIB1 kan; JMB111, IP2666 pIB1
 ; JMB141, IP2666
yscNU; JMB100, pIB1
 inv
 ; and JMB84, YPIII pIB1
 cTTSS.
Mouse infection. Seven– to 8-w-old female BALB/c (Taconic, or
Jackson Laboratories, Bar Harbor, Maine, United States), C.129S7
(B6)-Rag1
tm1Mom/J, Rag1
 /  (Jackson Laboratories), or C57BL6/J mice
(Jackson Laboratories) were used. Yptb were grown and infections
were performed as described in [27]. S. typhimurium and E. coli were
grown in LB at 37 8C overnight with aeration. Mice were infected
intragastrically with 200-ll PBS containing 2310
8 or 2310
9 Yptb, as
indicated in the ﬁgure legends, 5310
8 S. typhimurium, or 2310
8 E. coli.
Mice were infected i.p. with 200-ll PBS containing 1 3 10
6 Yptb. The
6-h, 2-d, 4-d, or 5-d post-intragastric inoculation or 3-d post-
intraperitoneal inoculation mice were sacriﬁced, and tissues were
dissected and processed as described in [27]; p-values were deter-
mined by two-tailed, unpaired Student t test by comparing the log
cfu/g tissue or log cfu/MLN of WT Yptb to each mutant.
The Institutional Animal Care and Use Committee of Tufts
University approved all animal procedures.
Histology and immunohistochemistry. MLN from uninfected mice
or mice infected intragastrically with 2 3 10
9 Yptb were dissected,
ﬁxed in formalin, embedded in parafﬁn, and cut in 10-lm sections.
Sections were treated with xylene to remove parafﬁn prior to staining
with hematoxylin-eosin or staining for immunohistochemistry.
Lauren Richey, DVM, PhD, Diplomat ACVP, and members of our
lab scored MLN histology sections blindly.
Immunohistochemistry was performed by treating the sections
with 3% hydrogen peroxide (DAKO, Glostrup, Denmark) for 5 min,
washing with 0.05% Tween-20 in PBS (PBS-Tw) for 5 min, incubating
with 1:100 rabbit anti-Yptb for 30 min, washing with PBS-Tw,
incubating with 1:300 polyclonal goat a-rabbit Ig (DAKO) for 30
min (gift from R. Isberg), washing with PBS-Tw, incubating with
streptavidin-HRP (DAKO) for 15 min, and then incubating with
substrate-chromatogen solution (DAKO). MLN were counterstained
with 0.5% hematoxylin and examined with a Nikon Eclipse TE2000-U
microscope (Melville, New York, United States).
Immunoﬂuorescence. MLN from uninfected mice or mice infected
intragastrically with 2310
9 with Yptb were harvested and snap frozen
in Optimal Cutting Temperature Compound (Tissue-Tek, Fort
Washington, Pennsylvania, United States). The 10-lm sections were
cut, ﬁxed with cold 100% acetone, and stored at 80 8C. For staining,
sections were washed with PBS and blocked with 2% BSA for 30 min.
Antibodies used were rat anti-mouse CD8 (BD Biosciences, San Jose,
California, United States) and rat anti-mouse CD4 (BD Biosciences)
for T lymphocytes, rat anti-mouse B220 (BD Biosciences) for B
lymphocytes, rat anti-mouse CD11b (BD Biosciences) for neutrophils
and macrophages, and rabbit anti-Yptb. Primary antibodies were
diluted 1:200 in 2% BSA and incubated with the samples for 3 h at
room temperature. Slides were washed three times with PBS-Tw for
15 min per wash and then incubated for 1 h with FITC conjugated to
donkey anti-rat (Jackson ImmunoResearch, West Grove, Pennsylva-
nia, United States) and Texas-Red–conjugated donkey anti-rabbit
antibodies (Jackson ImmunoResearch). Slides were washed three
times with PBS-Tw for 15 min per wash, and a cover slip was placed
over the tissue before visualization using 203,4 0 3 and 1003
objectives with a Nikon Eclipse TE2000-U microscope with ﬂuo-
rescence. Pictures were taken using a Roper Scientiﬁc camera
(Trenton, New Jersey, United States) controlled by Open Lab
software.
In vitro gentamicin protection assay. The macrophage cell line
RAW264.7 (ATCC# CRL-2278), the T cell line SUP-T1 (ATCC# CRL-
1942), and the T cell line H9 (ATCC# HTB-176) were grown as
recommended by ATCC (Manassas, Virginia, United States). Primary
B and T lymphocytes were isolated from MLN using enrichment
columns (Stem cells; R&D System, Minneapolis, Minnesota, United
States). Yptb strains were grown under Yop-inducing conditions [71].
A total of 5 3 10
4 or 2 3 10
5 cells were infected at a multiplicity of
infection (MOI) of 10:1 for 30 min at 37 8C in the presence of 5%
CO2. Gentamicin was added to a ﬁnal concentration of 100 lg/ml for
90 min, and then cells were washed three times with PBS. T and B
cells were centrifuged at 200 g for 5 min between each wash. Cells
were lysed with 100 ll of 1% Triton-X-100 for 5 min followed by
addition of 900-ll LB, and lysates were diluted and plated to
determine the number of intracellular bacteria. Results are presented
as percent uptake equal to 100 times the recovered cfu divided by the
input cfu.
Ex vivo gentamicin protection assay. MLN were dissected from 7–
8-wk female BALB/c mice infected with IP2666 or S. typhimurium. MLN
were placed in 1-ml RPMI on ice and then pressed through a 70-lm
ﬁlter (BD Labware, Palo Alto, California, United States) with the
rubber end of a 1-ml syringe plunger. The sample was divided into
two 0.5-ml aliquots: one aliquot was treated with 100-lg/ml
gentamicin for 2 h at 37 8C to kill extracellular bacteria, and the
other aliquot was untreated for 2 h at 37 8C to calculate the total cfu
recovered. Cells were washed three times with PBS and lysed with 100
ll of 1% Triton-X-100 for 5 min followed by addition of 900-ll LB,
and lysates were diluted and plated to determine the number of
intracellular bacteria. Results are presented as number of gentamicin
resistant bacteria (recovered after 2 h incubation) divided by the
input bacteria times 100.
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